Emergent Financial Statements From 2010 to 2024

EMGE Stock  USD 0  0.0001  9.09%   
Emergent Health financial statements provide useful quarterly and yearly information to potential Emergent Health Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Emergent Health financial statements helps investors assess Emergent Health's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Emergent Health's valuation are summarized below:
Emergent Health Corp does not presently have any fundamental signals for analysis.
Check Emergent Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emergent Health's main balance sheet or income statement drivers, such as , as well as many indicators such as . Emergent financial statements analysis is a perfect complement when working with Emergent Health Valuation or Volatility modules.
  
This module can also supplement various Emergent Health Technical models . Check out the analysis of Emergent Health Correlation against competitors.

Emergent Health Corp Company Operating Margin Analysis

Emergent Health's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Emergent Health Operating Margin

    
  (1.67) %  
Most of Emergent Health's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Emergent Health Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Emergent Health Corp has an Operating Margin of -1.6691%. This is 95.24% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 69.71% lower than that of the firm.

Emergent Health Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Emergent Health's current stock value. Our valuation model uses many indicators to compare Emergent Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Emergent Health competition to find correlations between indicators driving Emergent Health's intrinsic value. More Info.
Emergent Health Corp is rated # 2 in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Emergent Health's earnings, one of the primary drivers of an investment's value.

About Emergent Health Financial Statements

Emergent Health stakeholders use historical fundamental indicators, such as Emergent Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Emergent Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Emergent Health's assets and liabilities are reflected in the revenues and expenses on Emergent Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Emergent Health Corp. Please read more on our technical analysis and fundamental analysis pages.
Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. As of August 26, 2014, Emergent Health Corp was taken private. EMERGENT HEALTH operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Emergent Pink Sheet

Emergent Health financial ratios help investors to determine whether Emergent Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Emergent with respect to the benefits of owning Emergent Health security.